Table 3.
Correlation matrix between the 6 markers analysed in 20 tumour areas of 5 gonadotroph tumours
| ERα% | FSH% | Ki67% | LH% | S100B% | SSTR2% | |
|---|---|---|---|---|---|---|
| Spearman’s rho/adjusted p-value (Holm’s method)/n | ||||||
| ERα% | 0.67/0.01/20 | − 0.10/1/20 | 0.01/1/19 | 0.76/0.001/20 | 0.40/0.72/20 | |
| FSH% | 0.67/0.01/20 | − 0.50/0.23/20 | 0.43/0.60/19 | 0.78/0.0007/20 | 0.55/0.12/20 | |
| Ki67% | − 0.10/1/20 | − 0.50/0.23/20 | − 0.21/1/19 | − 0.31/1/20 | 0.01/1/20 | |
| LH% | 0.01/1/19 | 0.43/0.60/19 | − 0.21/1/19 | 0.31/1/19 | 0.13/1/19 | |
| S100B% | 0.76/0.002/20 | 0.78/0.0007/20 | − 0.31/1/20 | 0.31/1/19 | 0.34/1/20 | |
| SSTR2% | 0.40/0.72/20 | 0.55/0.12/20 | 0.01/1/20 | 0.13/1/19 | 0.34/1/20 | |
The correlations with an adjusted p-value (Holm’s method) < 0.05 are written in bold letters
oestrogen receptor alpha (ERα), follicle-stimulating hormone (FSH), luteinizing hormone (LH), somatostatin receptor type 2 (SSTR2), number of patients for which the data are available (n)